
Raymond J. Henley Iii
Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1205, 2899, 1629, 1614, 1621 |
| Total Applications | 4324 |
| Issued Applications | 3034 |
| Pending Applications | 603 |
| Abandoned Applications | 710 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7239215
[patent_doc_number] => 20040157861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Compositions and methods for inhibiting TGF-beta'
[patent_app_type] => new
[patent_app_number] => 10/747531
[patent_app_country] => US
[patent_app_date] => 2003-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13164
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10747531
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/747531 | Compositions and method for inhibiting TGF-β | Dec 28, 2003 | Issued |
Array
(
[id] => 7347201
[patent_doc_number] => 20040192703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Preferentially substituted calcium channel blockers'
[patent_app_type] => new
[patent_app_number] => 10/746933
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6850
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10746933
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/746933 | Preferentially substituted calcium channel blockers | Dec 22, 2003 | Issued |
Array
(
[id] => 963742
[patent_doc_number] => 06949554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-27
[patent_title] => 'Calcium channel blockers comprising two benzhydril moieties'
[patent_app_type] => utility
[patent_app_number] => 10/746932
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 7
[patent_no_of_words] => 8825
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/949/06949554.pdf
[firstpage_image] =>[orig_patent_app_number] => 10746932
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/746932 | Calcium channel blockers comprising two benzhydril moieties | Dec 22, 2003 | Issued |
Array
(
[id] => 7330206
[patent_doc_number] => 20040254228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Treatment of chronic heart failure'
[patent_app_type] => new
[patent_app_number] => 10/741709
[patent_app_country] => US
[patent_app_date] => 2003-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4646
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254228.pdf
[firstpage_image] =>[orig_patent_app_number] => 10741709
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/741709 | Treatment of chronic heart failure | Dec 18, 2003 | Abandoned |
Array
(
[id] => 7677058
[patent_doc_number] => 20040152768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'NO-synthase inhibitors comprising ascorbyl 2-hexadecanoate'
[patent_app_type] => new
[patent_app_number] => 10/733468
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4467
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152768.pdf
[firstpage_image] =>[orig_patent_app_number] => 10733468
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/733468 | NO-synthase inhibitors comprising ascorbyl 2-hexadecanoate | Dec 11, 2003 | Abandoned |
Array
(
[id] => 7675685
[patent_doc_number] => 20040126433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Light stabilized antimicrobial materials'
[patent_app_type] => new
[patent_app_number] => 10/734784
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2949
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20040126433.pdf
[firstpage_image] =>[orig_patent_app_number] => 10734784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/734784 | Light stabilized antimicrobial materials | Dec 11, 2003 | Issued |
Array
(
[id] => 7677091
[patent_doc_number] => 20040152735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'NO-synthase inhibitors comprising N,N\'-bis(2-pyridyl)methyl-N,N\'-bis(3,4,5-trimethoxybenzyl) ethylenediamine'
[patent_app_type] => new
[patent_app_number] => 10/733387
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4933
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152735.pdf
[firstpage_image] =>[orig_patent_app_number] => 10733387
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/733387 | NO-synthase inhibitors comprising N,N'-bis(2-pyridyl)methyl-N,N'-bis(3,4,5-trimethoxybenzyl) ethylenediamine | Dec 11, 2003 | Abandoned |
Array
(
[id] => 7674644
[patent_doc_number] => 20040127474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Regulators of the hedgehog pathway, compositions and uses related thereto'
[patent_app_type] => new
[patent_app_number] => 10/735116
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 32328
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127474.pdf
[firstpage_image] =>[orig_patent_app_number] => 10735116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/735116 | Regulators of the hedgehog pathway, compositions and uses related thereto | Dec 11, 2003 | Abandoned |
Array
(
[id] => 270572
[patent_doc_number] => 07563808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Methods for treating cognitive impairments or dementia'
[patent_app_type] => utility
[patent_app_number] => 10/732349
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8959
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563808.pdf
[firstpage_image] =>[orig_patent_app_number] => 10732349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/732349 | Methods for treating cognitive impairments or dementia | Dec 10, 2003 | Issued |
Array
(
[id] => 996333
[patent_doc_number] => 06913772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-05
[patent_title] => 'Composition useful as hepatoprotectants comprising extract of plant Cryptolepis buchanani and a method thereof'
[patent_app_type] => utility
[patent_app_number] => 10/735437
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4479
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/913/06913772.pdf
[firstpage_image] =>[orig_patent_app_number] => 10735437
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/735437 | Composition useful as hepatoprotectants comprising extract of plant Cryptolepis buchanani and a method thereof | Dec 10, 2003 | Issued |
Array
(
[id] => 7468195
[patent_doc_number] => 20040120986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Liquid oral compositions comprising a calcium compound and an acidulant'
[patent_app_type] => new
[patent_app_number] => 10/733992
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3961
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20040120986.pdf
[firstpage_image] =>[orig_patent_app_number] => 10733992
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/733992 | Liquid oral compositions comprising a calcium compound and an acidulant | Dec 9, 2003 | Issued |
Array
(
[id] => 7474111
[patent_doc_number] => 20040122010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Treatment of neuropathy'
[patent_app_type] => new
[patent_app_number] => 10/731905
[patent_app_country] => US
[patent_app_date] => 2003-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9631
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20040122010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10731905
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/731905 | Treatment of neuropathy | Dec 9, 2003 | Abandoned |
Array
(
[id] => 7672917
[patent_doc_number] => 20040180862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Compositions and methods for inhibiting bone resorption'
[patent_app_type] => new
[patent_app_number] => 10/479922
[patent_app_country] => US
[patent_app_date] => 2003-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6117
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10479922
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/479922 | Compositions and methods for inhibiting bone resorption | Dec 4, 2003 | Abandoned |
Array
(
[id] => 1018047
[patent_doc_number] => 06890941
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-10
[patent_title] => 'Compositions containing HMG Co-A reductase inhibitors and policosanol'
[patent_app_type] => utility
[patent_app_number] => 10/725405
[patent_app_country] => US
[patent_app_date] => 2003-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7155
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/890/06890941.pdf
[firstpage_image] =>[orig_patent_app_number] => 10725405
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/725405 | Compositions containing HMG Co-A reductase inhibitors and policosanol | Dec 2, 2003 | Issued |
Array
(
[id] => 7411432
[patent_doc_number] => 20040176456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-09
[patent_title] => 'Method of treatment for sexual dysfunction'
[patent_app_type] => new
[patent_app_number] => 10/726878
[patent_app_country] => US
[patent_app_date] => 2003-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6864
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20040176456.pdf
[firstpage_image] =>[orig_patent_app_number] => 10726878
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/726878 | Method of treatment for sexual dysfunction | Dec 1, 2003 | Issued |
Array
(
[id] => 7291408
[patent_doc_number] => 20040110800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Use of glucose uptake enhancer for reducing post-ischemic injury of the heart'
[patent_app_type] => new
[patent_app_number] => 10/725667
[patent_app_country] => US
[patent_app_date] => 2003-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4817
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110800.pdf
[firstpage_image] =>[orig_patent_app_number] => 10725667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/725667 | Use of glucose uptake enhancer for reducing post-ischemic injury of the heart | Dec 1, 2003 | Abandoned |
Array
(
[id] => 7352093
[patent_doc_number] => 20040248932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence'
[patent_app_type] => new
[patent_app_number] => 10/724856
[patent_app_country] => US
[patent_app_date] => 2003-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9539
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248932.pdf
[firstpage_image] =>[orig_patent_app_number] => 10724856
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/724856 | Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence | Nov 30, 2003 | Abandoned |
Array
(
[id] => 996636
[patent_doc_number] => 06914076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-05
[patent_title] => 'Treating chronic uremic patients undergoing periodical dialysis'
[patent_app_type] => utility
[patent_app_number] => 10/724175
[patent_app_country] => US
[patent_app_date] => 2003-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 3115
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/914/06914076.pdf
[firstpage_image] =>[orig_patent_app_number] => 10724175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/724175 | Treating chronic uremic patients undergoing periodical dialysis | Nov 30, 2003 | Issued |
Array
(
[id] => 497380
[patent_doc_number] => 07208477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-24
[patent_title] => 'Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases'
[patent_app_type] => utility
[patent_app_number] => 10/726327
[patent_app_country] => US
[patent_app_date] => 2003-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5577
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/208/07208477.pdf
[firstpage_image] =>[orig_patent_app_number] => 10726327
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/726327 | Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases | Nov 30, 2003 | Issued |
Array
(
[id] => 5035456
[patent_doc_number] => 20070099995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Use of hydroxyoleic acid and related compounds as functional food additives'
[patent_app_type] => utility
[patent_app_number] => 10/575190
[patent_app_country] => US
[patent_app_date] => 2003-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4335
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575190
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575190 | Use of hydroxyoleic acid and related compounds as functional food additives | Nov 27, 2003 | Abandoned |